Intermolecular provides high productivity combinatorial technology products and services for a wide range of industries. The Company's HPC platform, which consists of its Tempus processing tools, unique, automated characterization methods, and its Informatics analysis software, is purpose-built for research and development using combinatorial process systems in concert with established CVD, physical vapor deposition, and atomic layer deposition methods. Combinatorial processing is a methodology for experimentation, discovery, and development that employs parallel and other high-throughput experimentation, which allows R&D experimentation to be performed at speeds up to 100 times faster than conventional R&D platforms, which are optimized for manufacturing rather than for R&D.
TypePublic
HQSan Jose, US
Founded2004
Size (employees)145 (est)
Websiteintermolecular.com
Intermolecular was founded in 2004 and is headquartered in San Jose, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Intermolecular

Tony Chiang

Tony Chiang

CTO

Intermolecular Office Locations

Intermolecular has an office in San Jose
San Jose, US (HQ)
3011 N 1st St
Show all (1)
Report incorrect company information

Intermolecular Financials and Metrics

Intermolecular Revenue

Embed Graph
Intermolecular's revenue was reported to be $47.30 m in FY, 2016 which is a 4.4% increase from the previous period.
USD

Revenue (Q2, 2018)

19.5m

Gross profit (Q2, 2018)

13.2m

Gross profit margin (Q2, 2018), %

68%

Net income (Q2, 2018)

(127.0k)

EBIT (Q2, 2018)

(533.0k)

Market capitalization (15-Oct-2018)

56.2m

Closing stock price (15-Oct-2018)

1.1

Cash (30-Jun-2018)

4.3m
Intermolecular's current market capitalization is $56.2 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

67.4m47.7m45.3m47.3m

Revenue growth, %

(29%)(5%)4%

Cost of goods sold

32.5m24.7m19.3m15.8m

Gross profit

34.9m23.0m26.0m31.5m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Revenue

17.7m15.9m9.9m10.9m9.8m11.0m11.5m14.5m11.7m10.6m9.9m8.1m9.7m19.5m

Cost of goods sold

9.1m6.6m5.6m6.2m5.5m4.6m5.0m4.8m4.1m3.5m3.0m2.5m3.4m6.2m

Gross profit

8.7m9.3m4.3m4.7m4.4m6.4m6.5m9.7m7.6m7.1m7.0m5.5m6.3m13.2m

Gross profit Margin, %

49%59%43%43%44%58%56%67%65%67%70%69%65%68%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

72.1m21.8m11.7m5.8m

Inventories

2.2m1.8m1.6m1.4m

Current Assets

81.4m72.2m43.1m32.3m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Cash

74.3m72.3m41.8m22.1m25.6m14.4m3.3m17.1m16.4m9.7m7.6m6.5m4.4m4.3m

Accounts Receivable

2.8m4.2m1.9m

Inventories

7.5m7.3m7.4m

Current Assets

87.8m79.3m76.0m74.0m68.9m66.6m43.5m35.9m37.9m34.5m32.6m25.5m32.4m32.7m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(8.8m)(21.8m)(21.0m)(15.4m)

Depreciation and Amortization

10.9m

Inventories

2.2m1.6m1.6m

Accounts Payable

2.2m(635.0k)848.0k(493.0k)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

(2.2m)(3.9m)(6.9m)(5.0m)(7.0m)(5.7m)(5.8m)(1.7m)(4.0m)(6.8m)(5.8m)(623.0k)(127.0k)

Depreciation and Amortization

2.5m

Inventories

7.3m7.4m445.0k

Accounts Payable

1.1m221.0k(284.0k)1.1m1.8m224.0k786.0k327.0k746.0k(554.0k)(750.0k)
USDY, 2018

Financial Leverage

1.2 x
Show all financial metrics
Report incorrect company information

Intermolecular Online and Social Media Presence

Embed Graph
Report incorrect company information

Intermolecular Company Life and Culture

Report incorrect company information